XBiotech Inc. (XBIT) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.
Analysts estimate Earnings Per Share (EPS) of $-1.73 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.26 vs est $-1.73 (beat +27.2%). Analyst accuracy: 63%.
XBIT Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to XBiotech Inc. in the past 3 months
EPS Estimates — XBIT
63%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2024
Actual –$1.26
vs Est –$1.73
▲ 37.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — XBIT
Revenue Trend
Analysts expect stable revenue going forward.
